According to a recent study by doctors at Tufts HCM Center in collaboration with colleagues in Italy, exercise testing is an invaluable tool in the assessment of hypertrophic cardiomyopathy patient…
It may be possible for some athletes to continue playing competitive sports despite having an implantable defibrillator according to a recent study published in this week’s Circulation.
Sudden cardiac death in young athletes continues with alarming frequency. The most common cause of sudden death in the young athlete is hypertrophic cardiomyopathy or HCM.
Hypertrophic Cardiomyopathy - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version.
If you are looking for a good survey of current practices in the treatment of HCM, a recent article published in the journal Structural Heart by Dr. Ahmad Masri and the team at Oregon Health and Sc…
A close look at interventional cardiac procedures to treat obstructive hypertrophic cardiomyopathy.
According to a recent retrospective study at Oregon Health & Sciences University, appropriately selected patients 65 or older who underwent septal myectomy for obstructive hypertrophic cardiomy…
A recent study of Medicare patients conducted by doctors at the Cleveland Clinic found that senior citizens who underwent septal myectomy had better long term survival and did not need repeat proce…
A recent article published in the European Journal of Cardiology Heart Failure compares septal myectomy to septal alcohol ablation. The article emphasizes that proper patient selection for either p…
Lisa Salberg, Founder and CEO of the Hypertrophic Cardiomyopathy Association, underwent a successful heart transplant last week at New Jersey’s Newark Beth Israel Hospital. EDITED TO ADD STOR…
According to a recently published study by doctors in Copenhagen, Denmark, myocardial crypts are not necessarily an indicator of HCM.
A summary of current standards for the proper diagnosis and management of patients with hypertrophic cardiomyopathy was recently published by Australian HCM doctor Chris Semsarian in the journal He…
Hypertrophic cardiomyopathy affects the muscles of your heart, slowing blood and oxygen flow to the rest of your body.
The S-ICD is an option for heart patients who have had a prior cardiac arrest or a ventricular arrhythmia, or those with heart failure, which puts them at high risk for cardiac arrest.
An article by doctors at the Cleveland Clinic recently published in the Journal of the American Heart Association advocates for earlier surgical intervention for patients with obstructive hypertrop…
A study published this week by HCM researchers in Canada found that double mutations in patients with hypertrophic cardiomyopathy are much less common than previously thought. In particular, resear…
Heidi Rehm is a human geneticist and clinical laboratory director at Harvard Medical School who has spent much of her career studying the genetics of cardiomyopathy. Imagine her surprise when she f…
We found that exercise improves functional capacity in HCM patients. Since reduced functional capacity has been associated with worse outcomes in HCM and progression to heart failure, it is importa…
With the number of patients receiving permanent pacemakers (PPMs) and implantable cardioverter-defibrillators (ICDs) increasing each year, we'll
A recent paper shows how new advances in cardiac MRI and in new biomarkers identified through blood testing may help to identify subclinical HCM before overt signs are evident.
Doctors from the University of Pennsylvania published an article describing several new and/or experimental therapies which look promising for the future.
Reblogged on WordPress.com
A paper published this week in the Journal of the American College of Cardiology described the first beating heart septal myectomies performed on patients with obstructive HCM.
A recent study found that HCM is associated with mental health disorders. Mental health is an important issue which should not be overlooked by medical providers treating HCM patients.
The FDA has announced a Class I recall of certain models of Medtronic implantable defibrillators and cardiac resynchronization therapy defibrillators.
The latest news in current drug trials from MyoKardia and Cytokinetics.
MD Magazine has a nice feature about Dr. Robert Battle of the University of Virginia’s HCM Center.
Berritt Haynes, a 19 year old with hypertrophic cardiomyopathy, was chosen for Team Blake Shelton last night on the MGM Television/NBC television show THE VOICE.
The software update which allows the Apple Watch 4 to take an EKG and to detect atrial fibrillation went live last week. In anticipation of the availability of these functions, I purchased an Apple…
African-Americans with HCM tend to be younger and more symptomatic than their white counterparts.
Cardiomyopathy is a group of diseases that affect the heart muscle, leading to abnormal heart muscle function. This condition can
A recent Chinese study found that patients with hypertrophic cardiomyopathy who also suffered from clinical depression had a higher risk of sudden cardiac death and/or heart failure.
I was recently asked by the good people at MyoKardia, now a subsidiary of Bristol Myers Squibb, if I would author a plain language summary of an article to be published in the journal Future Cardio…
The FDA has announced a Class I recall of certain models of Medtronic implantable defibrillators and cardiac resynchronization therapy defibrillators.
A recent retrospective study conducted by doctors at Yale -New Haven Health System found that patients with hypertrophic cardiomyopathy fare best when treated at a specialty center us\ing a team ap…
Arrhythmia monitoring in HCM patients is used not only for determining risk of sudden death and need for an implantable defibrillator, but also for detecting atrial fibrillation and implementing an…
Sudden cardiac arrest (SCA) has had a moment in the public eye this week. Damar Hamlin’s misfortune shined a public light on the grim reality that we as HCM patients live with every day: the …
A recent study published in the New England Journal of Medicine found that drinkers suffering from atrial fibrillation who stopped drinking for the period of the study significantly reduced episode…
An article published today in Circulation by HCM experts Dr. Steve Ommen and Dr. Martin Maron discusses the prospective use of mavacamten as a treatment for obstructive hypertrophic cardiomyopathy.…
According to a recent article in the European Heart Journal, traditional cardiovascular risk factors such as obesity, hypertension and diabetes are associated with more severe forms of HCM.
A group of scientists working on gene therapy for inherited cardiomyopathies are seeking input from patients about their interest and willingness to participate in gene therapy trials. These resear…
Yet another company is developing a new drug for hypertrophic cardiomyopathy, and this time, the drug is intended for non-obstructive HCM patients.
As a HCM patient, I wish I could look forward to easing into old age without the need for surgery. But my 40+ years in health policy and government affairs has awakened me to all that can stand be…
Recently, Cynthia Waldman of HCMBeat corresponded with Dr. Srihari S. Naidu of Westchester Medical Center about the second edition of an HCM textbook he recently edited. What follows is a transcrip…
A recent study by several HCM genetics researchers around the globe, led by Australia’s Dr. Jodie Ingles, found that 2/3 of genetic mutations previously reported to patients as HCM causative …
A recent study published in Circulation suggests that clinical testing of kids who are first degree family members of HCM patients could be improved by starting testing at a younger age.
The FDA has announced a Class I recall of certain models of Medtronic implantable defibrillators and cardiac resynchronization therapy defibrillators.
